Health Berry Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
- Revenue Growth 44.01%
- Profit Growth -3.59%
- Ebitda 29.17%
- Net Worth 43.37%
- Total Assets -4.20%
About Health Berry Lifesciences
Health Berry Lifesciences Private Limited (HBLPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 August 2015 (Nine years and five months 29 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹4.50 M.
Jagdish Rai and Anju Rai serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233PN2015PTC156166
-
Company No.
156166
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Health Berry Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Rai
|
Director | 12-Aug-2015 | Current |
|
Anju Rai
|
Director | 05-May-2016 | Current |
Financial Performance of Health Berry Lifesciences.
Health Berry Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.01% increase. The company also saw a slight decrease in profitability, with a 3.59% decrease in profit. The company's net worth Soared by an impressive increase of 43.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health Berry Lifesciences?
In 2023, Health Berry Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2024 | Yes Bank Limited | ₹4.50 M | Open |
How Many Employees Work at Health Berry Lifesciences?
Unlock and access historical data on people associated with Health Berry Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health Berry Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health Berry Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
